- Home
- QNCX vs TMQ Comparison
QNCX vs TMQ Comparison
Compare QNCX & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- TMQ
- Stock Information
- Founded
- QNCX 2012
- TMQ 2004
- Country
- QNCX United States
- TMQ Canada
- Employees
- QNCX N/A
- TMQ N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- TMQ Precious Metals
- Sector
- QNCX Health Care
- TMQ Basic Materials
- Exchange
- QNCX Nasdaq
- TMQ Nasdaq
- Market Cap
- QNCX 47.7M
- TMQ 226.7M
- IPO Year
- QNCX 2019
- TMQ N/A
- Fundamental
- Price
- QNCX $2.00
- TMQ $1.70
- Analyst Decision
- QNCX Strong Buy
- TMQ
- Analyst Count
- QNCX 5
- TMQ 0
- Target Price
- QNCX $8.00
- TMQ N/A
- AVG Volume (30 Days)
- QNCX 374.6K
- TMQ 464.8K
- Earning Date
- QNCX 08-12-2025
- TMQ 07-10-2025
- Dividend Yield
- QNCX N/A
- TMQ N/A
- EPS Growth
- QNCX N/A
- TMQ N/A
- EPS
- QNCX N/A
- TMQ N/A
- Revenue
- QNCX N/A
- TMQ N/A
- Revenue This Year
- QNCX N/A
- TMQ N/A
- Revenue Next Year
- QNCX N/A
- TMQ N/A
- P/E Ratio
- QNCX N/A
- TMQ N/A
- Revenue Growth
- QNCX N/A
- TMQ N/A
- 52 Week Low
- QNCX $0.51
- TMQ $0.47
- 52 Week High
- QNCX $2.45
- TMQ $2.09
- Technical
- Relative Strength Index (RSI)
- QNCX 70.90
- TMQ 71.17
- Support Level
- QNCX $1.55
- TMQ $1.30
- Resistance Level
- QNCX $1.71
- TMQ $1.74
- Average True Range (ATR)
- QNCX 0.15
- TMQ 0.10
- MACD
- QNCX 0.02
- TMQ 0.04
- Stochastic Oscillator
- QNCX 89.09
- TMQ 90.91
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.